Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China · Delayed Price · Currency is CNY 21.07
-0.33 (-1.54%)
At close: Jan 30, 2026
SHE:301246 Market Cap
SHE:301246 has a market cap or net worth of 8.42 billion as of February 3, 2026. Its market cap has increased by 61.94% in one year.
Market Cap
8.42B
Enterprise Value
7.71B
Revenue
1.77B
Ranking
n/a
PE Ratio
592.31
Stock Price
21.07
Market Cap Chart
Since March 20, 2023, SHE:301246's market cap has decreased from 16.78B to 8.42B, a decrease of -49.80%. That is a compound annual growth rate of -21.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 8.27B | -16.64% |
| Dec 31, 2025 | 9.92B | 84.22% |
| Dec 31, 2024 | 5.39B | -48.18% |
| Dec 29, 2023 | 10.39B | -38.07% |
| Mar 20, 2023 | 16.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guilin Sanjin Pharmaceutical | 8.54B |
| Changchun BCHT Biotechnology Co. | 8.39B |
| Hainan Haiyao | 8.38B |
| China Animal Husbandry Industry | 8.34B |
| Renhe Pharmacy Co.,Ltd | 8.29B |
| Sunflower Pharmaceutical Group Co.,Ltd | 8.22B |
| Heilongjiang ZBD Pharmaceutical | 8.22B |
| Jiangsu Kanion Pharmaceutical | 8.20B |